MX362918B - Película mucoadhesiva que contiene nicotina y método para su fabricación. - Google Patents

Película mucoadhesiva que contiene nicotina y método para su fabricación.

Info

Publication number
MX362918B
MX362918B MX2014010760A MX2014010760A MX362918B MX 362918 B MX362918 B MX 362918B MX 2014010760 A MX2014010760 A MX 2014010760A MX 2014010760 A MX2014010760 A MX 2014010760A MX 362918 B MX362918 B MX 362918B
Authority
MX
Mexico
Prior art keywords
film
nicotine
solution
mean
weight
Prior art date
Application number
MX2014010760A
Other languages
English (en)
Other versions
MX2014010760A (es
Inventor
Hübinette Fredrik
Original Assignee
Nicoccino Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicoccino Ab filed Critical Nicoccino Ab
Publication of MX2014010760A publication Critical patent/MX2014010760A/es
Publication of MX362918B publication Critical patent/MX362918B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10Chemical features of tobacco products or tobacco substitutes
    • A24B15/16Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465Nicotine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007Drug-containing films, membranes or sheets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

La presente invención se refiere a un método de fabricación de una película mucoadhesiva que contiene nicotina, por la preparación de una solución acuosa a un pH desde 9.5 hasta 13, la solución comprende: (i) una sal de nicotina, (ii) un agente regulador del pH alcalino, y (iii) un agente formador de una película que comprende una sal de alginato del catión monovolante o una mezcla de las sales de alginato de los cationes monovalentes, el agente de formación de la película tiene un contenido de guluronato (G) promedio desde 50 hasta 85 % en peso, un contenido de manuronato (M) promedio desde 15 hasta 50 % en peso, un peso molecular promedio desde 30,000 g/mol hasta 90,000 g/mol y que es tal que una solución acuosa al 10 % de la misma a una temperatura de 20 °C tiene una viscosidad de 100-1000 mPas, como es medida a una velocidad de cizallamiento de 20 rpm por el uso de un viscosímetro de Brookfield con un husillo del No. 2; distribuir la solución sobre una superficie sólida; y permitir que la solución se seque sobre la superficie. También se refiere a una película mucoadhesiva que contiene nicotina.
MX2014010760A 2012-03-27 2013-03-15 Película mucoadhesiva que contiene nicotina y método para su fabricación. MX362918B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261615997P 2012-03-27 2012-03-27
EP12161483 2012-03-27
PCT/EP2013/055456 WO2013143891A1 (en) 2012-03-27 2013-03-15 Nicotine formulation

Publications (2)

Publication Number Publication Date
MX2014010760A MX2014010760A (es) 2015-03-20
MX362918B true MX362918B (es) 2019-02-26

Family

ID=49258262

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014010760A MX362918B (es) 2012-03-27 2013-03-15 Película mucoadhesiva que contiene nicotina y método para su fabricación.

Country Status (21)

Country Link
US (1) US20150096572A1 (es)
EP (1) EP2830589B1 (es)
JP (2) JP6412492B2 (es)
KR (1) KR102038342B1 (es)
CN (1) CN104411297B (es)
AU (1) AU2013242200B2 (es)
BR (1) BR112014023823B1 (es)
CA (1) CA2868445C (es)
HK (1) HK1205679A1 (es)
IN (1) IN2014DN08879A (es)
MX (1) MX362918B (es)
MY (1) MY183216A (es)
NZ (1) NZ626974A (es)
PL (1) PL2830589T3 (es)
RS (1) RS58677B1 (es)
RU (1) RU2625836C2 (es)
SG (1) SG11201405958RA (es)
SI (1) SI2830589T1 (es)
UA (1) UA116440C2 (es)
WO (1) WO2013143891A1 (es)
ZA (1) ZA201407677B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170172938A1 (en) * 2014-07-08 2017-06-22 Fertin Pharma A/S Oral delivery system comprising two compartments
EP3558267B1 (en) * 2016-12-20 2023-04-26 Fertin Pharma A/S A mucoadhesive oromucosal formulation comprising a nicotine complex
KR20210107690A (ko) * 2018-12-28 2021-09-01 필립모리스 프로덕츠 에스.에이. 금속염을 포함하는 니코틴 제형
CN113242696B (zh) * 2018-12-31 2023-04-28 菲利普莫里斯生产公司 液体尼古丁制剂
SE544672C2 (en) * 2020-05-07 2022-10-11 Liw Innovation Ab New compositions for oral or nasal use
WO2024037043A1 (zh) * 2023-04-28 2024-02-22 深圳华宝协同创新技术研究院有限公司 用于口腔粘膜的包含尼古丁的薄膜组合物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL86170A (en) 1987-05-01 1992-12-01 Elan Transdermal Ltd Preparations and compositions comprising nicotine for percutaneous administration
CA2178021C (en) * 1996-04-19 1999-09-28 Theodore H. Stanley Tobacco substitute
SE9900215D0 (sv) 1999-01-26 1999-01-26 Pharmacia & Upjohn Ab New use
JP5089840B2 (ja) * 2001-09-25 2012-12-05 救急薬品工業株式会社 ニコチン含有フィルム製剤
GB0508306D0 (en) * 2005-04-25 2005-06-01 Bioprogress Technology Ltd Nicotine dosage forms
SE530184C2 (sv) * 2005-12-23 2008-03-18 Kjell Stenberg Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater
US20080286340A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered nicotine containing products
US20080286341A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered coated nicotine containing products
EA021392B1 (ru) * 2007-10-11 2015-06-30 Филип Моррис Продактс С.А. Бездымный табачный продукт
CN101896172A (zh) * 2007-12-11 2010-11-24 诺瓦提斯公司 多区膜
EP2405942B1 (en) * 2009-03-13 2017-11-01 Excellent Tech Products i Sverige AB Oral delivery product

Also Published As

Publication number Publication date
MX2014010760A (es) 2015-03-20
KR102038342B1 (ko) 2019-10-30
RU2014143003A (ru) 2016-05-20
EP2830589A1 (en) 2015-02-04
IN2014DN08879A (es) 2015-05-22
UA116440C2 (uk) 2018-03-26
NZ626974A (en) 2016-09-30
US20150096572A1 (en) 2015-04-09
HK1205679A1 (en) 2015-12-24
SG11201405958RA (en) 2014-10-30
ZA201407677B (en) 2016-05-25
KR20140140021A (ko) 2014-12-08
CA2868445A1 (en) 2013-10-03
WO2013143891A1 (en) 2013-10-03
CN104411297B (zh) 2017-10-24
SI2830589T1 (sl) 2019-06-28
JP2015516948A (ja) 2015-06-18
JP6412492B2 (ja) 2018-10-24
JP2017226686A (ja) 2017-12-28
BR112014023823A2 (es) 2017-06-20
PL2830589T3 (pl) 2019-07-31
RU2625836C2 (ru) 2017-07-19
MY183216A (en) 2021-02-18
AU2013242200B2 (en) 2017-03-02
CA2868445C (en) 2020-01-28
RS58677B1 (sr) 2019-06-28
CN104411297A (zh) 2015-03-11
EP2830589B1 (en) 2019-02-13
BR112014023823B1 (pt) 2022-04-26
AU2013242200A1 (en) 2014-10-16

Similar Documents

Publication Publication Date Title
MX362918B (es) Película mucoadhesiva que contiene nicotina y método para su fabricación.
SE0502900L (sv) Komposition och metod
MX340625B (es) Composicion de recubrimiento.
EA031696B9 (ru) Полутвердый пищевой концентрат в виде пасты или геля
MX2013002153A (es) Composiciones y metodos para mejorar la compatibilidad de las sales herbicidas solubles en agua.
BR112014017403A2 (pt) distribuidor de produto sólido de dissolução controlada
NZ763651A (en) Aerosolisable formulation
MX2015017854A (es) Composicion que comprende glutamico-n, n-diacetato (glda), agua y enzima.
UA117343C2 (uk) Композиції целюлози, способи одержання композицій целюлози і продукти, що містять композиції целюлози
FR2999086B1 (fr) Composition orale et/ou buccale sous forme de film fin d'un principe actif faiblement soluble, son procede de preparation et son utilisation
MX2017003052A (es) Recubrimientos de silicato.
MX2016002837A (es) Una particula antimicrobiana y composiciones de la misma.
SG11202000445TA (en) Coating composition, coating film, and coating preparation and method for producing same
WO2013037965A3 (en) Ionic gel
MX354454B (es) Procedimiento de elaboracion de microcapsulas entericas de alginato por gelacion ionica que contienen diclofenac o una de sus sales y composicion farmaceutica multiparticulada que las contiene.
PL390296A1 (pl) Sposób wytwarzania nanoproszków krzemionkowych o właściwościach biobójczych, zwłaszcza do kompozytów polimerowych
RU2010129860A (ru) Способ получения тонких пленок диоксида олова
BR112014018138A8 (pt) Composição de tratamento de superfície, meio de impressão e método para preparar uma composição de tratamento de superfície utilizada na fabricação de papel
UA118581C2 (uk) Зволожувальні агенти
AU2016220032B2 (en) Stabilizing sorbic acid in beverage syrup
MX2020005890A (es) Formulacion de pelicula que comprende vardenafil, metodo para su preparacion y uso de la misma.
WO2010105970A3 (de) Zusammensetzung enthaltend suspendiertes pestizid, salz und polysaccharid
TR201905664T4 (tr) Nikotin formülasyonu.
MX2019012085A (es) Composición líquida de suspensión de esmectita y método de preparación de la misma.
MX2019001238A (es) Recubrimientos faciles de tragar y sustratos recubiertos con estos.

Legal Events

Date Code Title Description
FG Grant or registration